ARCHIVES

GSK’s Votrient Approved For Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 10 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation

November 27, 1987

Flint Chop Shows That Successful Community Program Can Be Developed And Operated Without NCI Funding

January 21, 1983

Program Project Guidelines Available

October 27, 1995

Zerhouni Announces Changes To NIH Peer Review.

June 6, 2008